 REDWOOD CITY, CA ACCESSWIRE January 15, 2021 Avinger, Inc. NASDAQ:AVGR, a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of Peripheral Artery Disease PAD, today announced full commercial launch of its TigereyeTM image-guided chronic total occlusion CTO crossing system. With the initiation of full commercial launch, current and prospective accounts throughout the US and Germany are now able to order the Tigereye device. 